Evidence map›Paper›PMID 39350129›Full record

ArticleBMC medical genomics2024

Identification of a novel intronic variant in COL4A2 gene associated with fetal severe cerebral encephalomalacia and subdural hemorrhage.

Rong-Yue Sun, Yue Xu, Qing-Qing Huang, Si-Si Hu, Hua-Zhi Xu, Yan-Zhao Luo, Ting Zhu, Jun-Hui Sun, Yu-Jing Gong, Mian-Mian Zhu and 4 more

Abstract readCase Reports
In one paragraph

Article in BMC medical genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rong-Yue Sun *Department of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Yue Xu *Department of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Qing-Qing Huang *Department of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Si-Si HuDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Hua-Zhi XuDepartment of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yan-Zhao LuoDepartment of Pediatrics, Lishui People's Hospital, Lishui, Zhejiang, China.
Ting ZhuDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Jun-Hui SunReproductive Medicine Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yu-Jing GongDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Mian-Mian ZhuDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China.
Hong-Wei WangKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jing-Ye PanKey Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Chao-Sheng LuDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China. lucs363@163.com.
Dan WangDepartment of Pediatrics, the First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Road, Wenzhou, Zhejiang, 325000, China. wd608044@wmu.edu.cn.

Funding

Medical Science and Technology Project of Zhejiang Province 2022YK839National Natural Science Foundation of China 82171701The Social Programs of Wenzhou Technology Bureau 2023Y0329
6 · The paper itself

Abstract

backgroundGenetic variants in COL4A2 are less common than those of COL4A1 and their fetal clinical phenotype has not been well described to date. We present a fetus from China with an intronic variant in COL4A2 associated with a prenatal diagnosis of severe cerebral encephalomalacia and subdural hemorrhage.

methodsWhole exome sequencing (WES) was applied to screen potential genetic causes. Bioinformatic analysis was performed to predict the pathogenicity of the variant. In in vitro experiment, the minigene assays were performed to assess the variant's effect.

resultsIn this proband, we observed ventriculomegaly, subdural hemorrhage, and extensive encephalomalacia that initially suggested cerebral hypoxic-ischemic and/or hemorrhagic lesions. WES identified a de novo heterozygous variant c.549 + 5G > A in COL4A2 gene. This novel variant leads to the skipping of exon 8, which induces the loss of 24 native amino acids, resulting in a shortened COL4A2 protein (p.Pro161_Gly184del).

conclusionOur study demonstrated that c.549 + 5G > A in COL4A2 gene is a disease-causing variant by aberrant splicing. This finding enriches the variant spectrum of COL4A2 gene, which not only improves the understanding of the fetal neurological disorders associated with hypoxic-ischemic and hemorrhagic lesions from a clinical perspective but also provides guidance on genetic diagnosis and counseling.

Indexed as

Collagen Type IVHematoma, SubduralIntronsChild, PreschoolExome SequencingFatal OutcomeFemaleHumansMalePregnancyPrenatal DiagnosisCOL4A2 protein, humanCollagen Type IVCOL4A2EncephalomalaciaHeterozygous intronic variantMinigene splicing assays

Identifiers

PMID39350129
PMCPMC11441077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.